| State: | New Jersey |
|---|---|
| Address: | 8 Clarke Dr #4, Cranbury, NJ 08512 |
| Zip code: | 08512 |
| Phone: | (609) 662-1913 |
| Website: | http://www.kluspharma.com/ |
| Monday: | 8:30 AM – 6:00 PM |
|---|---|
| Tuesday: | 8:30 AM – 6:00 PM |
| Wednesday: | 8:30 AM – 6:00 PM |
| Thursday: | 8:30 AM – 6:00 PM |
| Friday: | 8:30 AM – 6:00 PM |
| Saturday: | Closed |
| Sunday: | Closed |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about KLUS Pharma, Inc, use the form below and your opinion, advice or comment will appear in this space.
The phone number for KLUS Pharma, Inc is (609) 662-1913.
KLUS Pharma, Inc is located at 8 Clarke Dr #4, Cranbury, NJ 08512
The website (URL) for KLUS Pharma, Inc is: http://www.kluspharma.com/
KLUS Pharma, Inc is open:
Monday:8:30 AM – 6:00 PM
Tuesday:8:30 AM – 6:00 PM
Wednesday:8:30 AM – 6:00 PM
Thursday:8:30 AM – 6:00 PM
Friday:8:30 AM – 6:00 PM
Saturday:Closed
Sunday:Closed
8 Clarke drive, Cranbury, New Jersey 08512 Tel. 609-662-1913
(609) 662-1913. Fax: (609) 662-1918. Website: www.kluspharma.com. More. Description: Klus Pharma, Inc. was established in 2014. Klus Pharma is a niche pharmaceutical ...
Klus Pharma, Inc. was established in 2014. Klus Pharma is a niche pharmaceutical company located in the Princeton area of New Jersey. We focus on generic pharmaceutical development, manufacturing, sales & marketing as well as APIs in North American...
Klus Pharma Inc. Information provided by (Responsible Party): ... 609-662-1913: Clinicaltrialinfo@kluspharma.com: Locations. Layout table for location information;
Source: Klus Pharma Inc. Brief Summary Open-label, Phase I-II, first-in-human (FIH) study for A166 monotherapy in HER2-expressing or amplified patients who progressed on or did not respond to available standard therapies.
Overview. Open-label, Phase I-II, first-in-human (FIH) study for A166 monotherapy in HER2-expressing or amplified patients who progressed on or did not respond to available standard therapies.